Below (from the last quarterly) is where we need to see meaningful progress in the upcoming quarterly.
Licences contracted (sales) is clearly no longer a question or concern. That line is headed one way.
Licenses implemented is the concern. If that shows significant improvement, imo, the rest is cake.
"We are on track to achieve our initial business goal of $4.8M ARR, or 100,000 beds, which would represent an operational break even number excluding R&D, overheads and investment in new markets". They should achieve this by EOCY.
PCK Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
